US Patent Issued to TAIHO PHARMACEUTICAL on Oct. 7 for "Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1" (Japanese Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,128, issued on Oct. 7, was assigned to TAIHO PHARMACEUTICAL Co. LTD. (Tokyo).

"Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1" was invented by Ryo Hatanaka (Tsukuba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for predicting a therapeutic effect of a chemotherapy using an antitumor agent comprising an LSD1 inhibitor in a cancer patient based on an expression level of INSM1 in a sample containing tumor cells isolated from the cancer patient."

The patent was filed on May 30, 2018, under Application No. 16/617,866.

*For further information, including images, charts and tables, please visit: ht...